Two Pep Pills in Big Pharma
This downtrodden sector may see better days in 2003, with Pfizer and Lilly having particularly good potential for healthier stocks
By David Shook
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like: